GLPBio

Hydroxy/Hydroperoxy/Epoxy/Oxo Eicosanoids

Products Related to Hydroxy/Hydroperoxy/Epoxy/Oxo Eicosanoids(138)

  • GC20027 structure
    GC20027(±)5(6)-DiHET MaxSpec® Standard
    CAS: 213382-49-1
    Purity: >95.00%

    5(6)-DiHET is a fully racemic version of the enantiomeric forms biosynthesized from 5(6)-EET by epoxide hydrolases.

  • GC40268 structure
    GC40268(±)14(15)-DiHET
    Purity: >98.00%

    Epoxide hydrolases convert the EETs into vicinal diols, with the concurrent loss of much of their biological activity.

  • GC40271 structure
    GC40271(±)5(6)-DiHET MaxSpec® Standard
    CAS: 213382-49-1
    Purity: >95.00%

    5(6)-DiHET is a fully racemic version of the enantiomeric forms biosynthesized from 5(6)-EET by epoxide hydrolases.

  • GC40272 structure
    GC40272(±)8(9)-DiHET
    CAS: 192461-96-4
    Purity: >98.00%

    Epoxide hydrolases convert the EETs into vicinal diols, with the concurrent loss of much of their biological activity.

  • GC40279 structure
    GC40279(±)11(12)-DiHET
    Purity: >98.00%

    Epoxide hydrolases convert the EETs into vicinal diols, with the concurrent loss of much of their biological activity.

  • GC40339 structure
    GC40339Hepoxilin A3 methyl ester
    Purity: >98.00%

    Hepoxilin A3 (HxA3) methyl ester is an ester version of HxA3 that more potently induces calcium release from intracellular stores and then induces calcium influx in suspended human neutrophils.

  • GC40349 structure
    GC4034912(S)-HETE-19,20-alkyne
    Purity: >97.00%

    12(S)-HETE is the predominant lipoxygenase product of mammalian platelets.

  • GC40359 structure
    GC40359(±)12-HEPE
    CAS: 81187-21-5
    Purity: >98.00%

    (±)12-HEPE is produced by non-enzymatic oxidation of EPA.

  • GC40360 structure
    GC40360(±)14(15)-EpETE
    CAS: 131339-24-7
    Purity: >90.00%

    EDHF (endothelium-derived hyperpolarizing factor) is an unidentified mediator released from vascular endothelial cells in response to acetylcholine and bradykinin which is distinct from the NOS- (nitric oxide) and COX-derived (prostacyclin) vasodilators.

  • GC40361 structure
    GC40361(±)15-HEPE
    CAS: 88852-33-9
    Purity: >98.00%

    (±)15-HEPE is produced by non-enzymatic oxidation of EPA.

  • GC40362 structure
    GC40362(±)18-HEPE
    CAS: 141110-17-0
    Purity: >95.00%

    (±)18-HEPE is produced by non-enzymatic oxidation of EPA.

  • GC40363 structure
    GC40363(±)5(6)-DiHETE lactone
    Purity: >90.00%

    Eicosapentaenoic acid is metabolized, in part, through cytochrome P450-catalyzed epoxidation followed by conversion to the vicinal diols by epoxide hydrolases.

  • GC40364 structure
    GC40364(±)5-HEPE
    CAS: 83952-40-3
    Purity: >97.00%

    (±)5-HEPE is produced by non-enzymatic oxidation of EPA.

  • GC40365 structure
    GC40365(±)8(9)-EpETE
    CAS: 851378-93-3
    Purity: >95.00%

    Eicosapentaenoic acid is converted to epoxyeicosatetraenoic acids (EpETEs) by several cytochrome P450 isoforms.

  • GC40366 structure
    GC40366(±)8-HEPE
    CAS: 99217-77-3
    Purity: >98.00%

    (±)8-HEPE is produced by non-enzymatic oxidation of EPA.

  • GC40367 structure
    GC40367(±)9-HEPE
    CAS: 286390-03-2
    Purity: >98.00%

    (±)9-HEPE is produced by non-enzymatic oxidation of EPA.

  • GC40368 structure
    GC4036811(R)-HEPE
    CAS: 109430-11-7
    Purity: >98.00%

    11(R)-HEPE is produced by the oxidation of EPA by 11(R)-LO.

  • GC40369 structure
    GC4036911(S)-HEPE
    CAS: 156473-26-6
    Purity: >98.00%

    11(S)-HEPE is a monohydroxy fatty acid derived from EPA, theoretically by the action of COX.

  • GC40370 structure
    GC4037012(R)-HEPE
    CAS: 109430-12-8
    Purity: >98.00%

    12(R)-HEPE is a monohydroxy fatty acid synthesized from EPA by the eggs of the sea urchin, S.

  • GC40371 structure
    GC4037112(S)-HEPE
    CAS: 116180-17-7
    Purity: >98.00%

    12(S)-HEPE is a monohydroxy fatty acid synthesized from EPA by the action of 12-LO.

  • GC40372 structure
    GC4037212-OxoETE
    CAS: 108437-64-5
    Purity: >90.00%

    12-OxoETE is synthesized by human platelets and Aplysia nervous tissue after incubation with arachidonic acid.

  • GC40373 structure
    GC4037315(S)-HEPE
    CAS: 86282-92-0
    Purity: >98.00%

    15(S)-HEPE is a monohydroxy fatty acid synthesized from EPA by the action of 15-LO.

  • GC40374 structure
    GC4037415(S)-HEPE MaxSpec® Standard
    CAS: 86282-92-0
    Purity: >95.00%

    15(S)-HEPE is a monohydroxy fatty acid synthesized from EPA by the action of 15-LO.

  • GC40376 structure
    GC4037615-OxoETE
    CAS: 81416-72-0
    Purity: >98.00%

    15-OxoETE is produced by oxidation of the 15-hydroxyl of 15-HETE.